KCS Wealth Advisory’s Clorox CLX Stock Holding History

KCS Wealth Advisory’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37	Closed	-$5.62K	–	192
2019 Q3	$5.62K	Buy	+37	New	+$5.85K	﹤0.01%	384

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

KCS Wealth Advisory's CLX Position: Q4 2019 in Review

KCS Wealth Advisory sold out of Clorox (CLX) in Q4 2019, closing a stake of 37 shares — an estimated $5.62K sold.

KCS Wealth Advisory first reported a position in CLX in Q3 2019 and held it in 1 quarter. The position peaked at $5.62K in Q3 2019. 1,030 funds tracked by Wall St. Rank hold CLX as of Q4 2019.

KCS Wealth Advisory reported no remaining Clorox position as of Q4 2019 after selling out during the quarter.
KCS Wealth Advisory sold 37 Clorox shares in Q4 2019, an estimated $5.62K.
KCS Wealth Advisory first reported a position in Clorox in Q3 2019 and held it in 1 quarter.
KCS Wealth Advisory's Clorox position peaked at $5.62K in Q3 2019.
1,030 funds tracked by Wall St. Rank held Clorox as of Q4 2019.

Based on KCS Wealth Advisory's 13F filing for Q4 2019, filed 15 Jan 2020.